148 biomarkers
| Chapter | Eye_Biomarker | Systematic_Disease | Category |
|---|---|---|---|
| Chapter II | A recalcitrant or atypical hypopyon uveitis | a blast crisis or a central nervous system involvement or sign of a relapse in cases of leukemia | Disease |
| Chapter II | a white fundus mass | bladder cancer | Bio-imaging |
| Chapter II | acquired night blindness | gastrointestinal neoplasia | Disease |
| Chapter II | acute pain and abrupt loss of sight in the left eye accompanied by its enlargement. | non-seminomatous germ cell testicular tumor | Disease |
| Chapter II | adhesion to optic nerve | tuberculum sellae meningiomas | Other |
| Chapter II | age-related macular degeneration | myeloproliferative neoplasms (MPNs) | Disease |
| Chapter II | amaurosis fugax (AmF) | ovary tumor | Symptom |
| Chapter II | anterior uveitis with hypopyon | letterer-siwe disease(LSD) | Disease |
| Chapter II | atypical vitritis | bladder cancer | Disease |
| Chapter II | atypical vitritis 、a white fundus mass | bladder cancer | Disease |
| Chapter II | B-cell activating factor (BAFF) | uveal melanoma | Protein |
| Chapter II | Bilateral Diffuse Uveal Melanocytic Proliferation | lung cancer | Disease |
| Chapter II | Bilateral Diffuse Uveal Melanocytic Proliferation | non-small-cell lung cancer (NSCLC) | Disease |
| Chapter II | Bilateral multifocal uveal juvenile xanthogranuloma | letterer-siwe disease(LSD) | Disease |
| Chapter II | blurred vision | lung cancer | Symptom |
| Chapter II | blurred vision | non-small-cell lung cancer (NSCLC) | Symptom |
| Chapter II | cancer-associated retinopathy (CAR) | small-cell carcinoma of the lung (SCCL) | Disease |
| Chapter II | carbohydrate antigen-125, calcium, and hemoglobin | malignant neoplasm of liver | Metabolite |
| Chapter II | cataract | ovarian carcinoma | Disease |
| Chapter II | cataract extraction | breast cancer | Therapy |
| Chapter II | centromere protein E | retinoblastoma | Protein |
| Chapter II | Choroidal Mucinous Metastatic Adenocarcinoma from the Colon | colon adenocarcinoma | Disease |
| Chapter II | Circular RNA HIPK3 | malignant neoplasms | Nucleic Acids-Based Biomarker |
| Chapter II | clusterin | retinal hemangioblastoma | Protein |
| Chapter II | color loss | small-cell carcinoma of the lung (SCCL) | Symptom |
| Chapter II | colour vision deficiencies | melanoma | Other |
| Chapter II | congenital hypertrophy of retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | congenital hypertrophy of retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | congenital hypertrophy of retinal pigment epithelium (CHRPE) | adenomatous polyposis coli (APC) | Bio-imaging |
| Chapter II | congenital hypertrophy of retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Eye measures |
| Chapter II | congenital hypertrophy of retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | congenital hypertrophy of retinal pigment epithelium (CHRPE) | familial colonic polyposis | Bio-imaging |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | colorectal polyposis in Gardner's syndrome | Bio-imaging |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial colorectal cancer | Bio-imaging |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | gardner's syndrome | Eye measures |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Disease |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Disease |
| Chapter II | congenital hypertrophy of the retinal pigment epithelium (CHRPE) | familial adenomatous polyposis(FAP) | Disease |
| Chapter II | conjunctival acanthosis nigricans | adenocarcinoma of the lung | Disease |
| Chapter II | conjunctival acanthosis nigricans | adenocarcinoma of the lung | Disease |
| Chapter II | CXCL5/CXCL8 | Hepatocellular carcinoma (HCC) | Nucleic Acids-Based Biomarker |
| Chapter II | diplopia and progressing to ptosis of the left palpebra and subsequent complete closure of the eye | gallbladder cancer | Symptom |
| Chapter II | diplopia、slight limitation of the lateral movement of the left eye | primary T cell type malignant lymphoma of the sellar region | Eye measures |
| Chapter II | either flat or greatly reduced electroretinograms | small-cell carcinoma of the lung (SCCL) | Eye measures |
| Chapter II | Eye absent homolog 4(EYA4) | hepatocellular carcinoma(HCC) | Nucleic Acids-Based Biomarker |
| Chapter II | eye color | cutaneous cancer | Eye measures |
| Chapter II | eye colour | basal cell carcinoma (BCC) | Eye measures |
| Chapter II | eye colour | squamous cell carcinoma (SCC) | Eye measures |
| Chapter II | eye movement disorders (opsoclonus) | breast cancer | Symptom |
| Chapter II | globe protrusion | spheno-orbital meningiomas | Eye measures |
| Chapter II | high cysteinyl leukotriene receptor 1 (CysLT1) | malignant melanoma | Protein |
| Chapter II | higherexfoliationglaucoma(XFG) | nonmelanoma skin cancer(NMSC) | Disease |
| Chapter II | hypertrophy of retinal pigmented epithelium | familial polyposis coli | Bio-imaging |
| Chapter II | immune cell infiltration | malignant neoplasm of eye and adnexa, uveal melanoma | Other |
| Chapter II | including anti-anti-retinalautoantibodies，recoverin,anti-transducin-alpha,and anti-carbonicanhydraseIIantibodies | breast cancer | Protein |
| Chapter II | including anti-anti-retinalautoantibodies，recoverin,anti-transducin-alpha,and anti-carbonicanhydraseIIantibodies | colon cancer | Protein |
| Chapter II | including anti-anti-retinalautoantibodies，recoverin,anti-transducin-alpha,and anti-carbonicanhydraseIIantibodies | hematologic malignancies | Protein |
| Chapter II | including anti-anti-retinalautoantibodies，recoverin,anti-transducin-alpha,and anti-carbonicanhydraseIIantibodies | lung cancer | Protein |
| Chapter II | including anti-anti-retinalautoantibodies，recoverin,anti-transducin-alpha,and anti-carbonicanhydraseIIantibodies | melanoma | Protein |
| Chapter II | including anti-anti-retinalautoantibodies，recoverin,anti-transducin-alpha,and anti-carbonicanhydraseIIantibodies | prostate cancer | Protein |
| Chapter II | including anti-anti-retinalautoantibodies，recoverin,anti-transducin-alpha,and anti-carbonicanhydraseIIantibodies | prostate cancer | Protein |
| Chapter II | initialvisualfield | craniopharyngioma | Eye measures |
| Chapter II | iris flocculi | ciliary body melanoma | Disease |
| Chapter II | iris pigmented lesions | cutaneous melanoma(CM) | Eye measures |
| Chapter II | lacryglobin in human tears | breast cancer | Protein |
| Chapter II | lacryglobin in human tears | cancer | Protein |
| Chapter II | lengsin splicing variant 4 | lung cancer | Protein |
| Chapter II | lengsin splicing variant 4 | lung cancer | Protein |
| Chapter II | malignant lymphoma infiltrating the | malignant lymphoma | Disease |
| Chapter II | melanocortin 1 receptor | uveal melanoma | Protein |
| Chapter II | metastasis-associated in colon cancer 1 (MACC1) | retinoblastoma tumour | Protein |
| Chapter II | metastatic breast cancer to the cavernous sinus and orbit | breast cancer | Disease |
| Chapter II | metastatic disease to the lacrimal gland | anorectal squamous cell carcinoma | Disease |
| Chapter II | metastatic retinoblastoma | myelodysplastic syndrome | Disease |
| Chapter II | microphthalmia transcription factor | cutaneous melanoma(CM) | Protein |
| Chapter II | nestin | melanoma | Protein |
| Chapter II | new plaques and tumors on her eyebrows and eyelid margin, and alopecia of her eyelashes and eyebrow | mycosis fungoides/ cutaneous T-cell lymphoma | Disease |
| Chapter II | night blindness | small-cell carcinoma of the lung (SCCL) | Symptom |
| Chapter II | nonspecific pigmentary retinal changes | gastrointestinal neoplasia | Bio-imaging |
| Chapter II | ocular melanoma | hepatic metastases from melanoma | Disease |
| Chapter II | ocular melanoma | myelodysplastic syndrome | Disease |
| Chapter II | ocular metastasis in male liver cancer | liver cancer | Disease |
| Chapter II | ocular metastasis of lung adenocarcinoma | lung adenocarcinoma | Disease |
| Chapter II | ocular surface squamous neoplasia (OSSN) | cervical tumor | Disease |
| Chapter II | oculodermal melanocytosis | melanoma | Other |
| Chapter II | optic neuropathy | chronic lymphocytic leukemia | Disease |
| Chapter II | outer retinal membrane protein 1 | lung cancer | Protein |
| Chapter II | paraneoplastic ataxia and eye movement disorders (opsoclonus) | breast cancer | Other |
| Chapter II | paraneoplastic retinopathies (PR) | breast neoplasms | Disease |
| Chapter II | paraneoplastic retinopathies (PR) | colon cancer | Disease |
| Chapter II | paraneoplastic retinopathies (PR) | lung neoplasms | Disease |
| Chapter II | paraneoplastic retinopathies (PR) | melanoma | Disease |
| Chapter II | paraneoplastic retinopathies (PR) | prostate neoplasms | Disease |
| Chapter II | pattern electroretinogram | pituitary tumours | Eye measures |
| Chapter II | peptide nanofibrous indicator (NFI) | liver cell carcinoma | Protein |
| Chapter II | pigmented ocular fundus lesions | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | pigmented ocular fundus lesions | familial adenomatous polyposis(FAP) | Disease |
| Chapter II | postoperative visual field | pituitary tumor | Eye measures |
| Chapter II | presence of ptosis , refractive errors, strabismus, proptosis , and amblyopia | periocular infantile hemangiomas | Disease |
| Chapter II | primary angle-closure glaucoma | harboring secretory pituitary tumors | Disease |
| Chapter II | primary ocular hypertension | harboring secretory pituitary tumors | Eye measures |
| Chapter II | proliferative diabetic retinopathy | promyelocytic leukemia | Disease |
| Chapter II | pterygia | cutaneous melanoma(CM) | Disease |
| Chapter II | rapid vision loss | small-cell carcinoma of the lung (SCCL) | Symptom |
| Chapter II | recalcitrant or atypical hypopyon uveitis | blast crisis or a central nervous system involvement or sign of a relapse in cases of leukemia | Other |
| Chapter II | retinal nerve fiber layer (RNFL) thickness | meningioma | Bio-imaging |
| Chapter II | retinal pigment epithelium (RPE) lesions | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | retinal pigment epithelium (RPE) lesions | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | retinal pigment epithelium (RPE) lesions | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | retinal pigmentation | familial adenomatous polyposis(FAP) | Bio-imaging |
| Chapter II | retinoblastoma | metastasis-associated in colon cancer | Disease |
| Chapter II | retrobulbar tumor | Hepatocellular carcinoma (HCC) | Disease |
| Chapter II | retrobulbar tumor | Hepatocellular carcinoma (HCC) | Disease |
| Chapter II | S-100 protein | ocular malignant melanoma | Protein |
| Chapter II | segmented retinal layer | pituitary adenoma (PA) | Bio-imaging |
| Chapter II | serum antibodies to retinal antigens | lung cancer | Protein |
| Chapter II | serum VEGF | melanoma | Protein |
| Chapter II | slow and fast phase velocities of optokinetic nystagmus | acoustic tumors | Eye measures |
| Chapter II | subconjunctival lymphoma | gastrointestinal tumor | Disease |
| Chapter II | subconjunctival lymphoma、dry eye | pulmonary lymphoma | Disease |
| Chapter II | tear proteomic pattern | breast cancer | Protein |
| Chapter II | tumor in the conjunctiva | mantle cell lymphoma with multiple extranodal involvement | Disease |
| Chapter II | uveal melanoma (UM) | uveal melanoma liver metastasis | Disease |
| Chapter II | uveal melanoma (UM) | liver metastases | Disease |
| Chapter II | uveal melanoma (UM) | liver metastases | Disease |
| Chapter II | vision | pituitary adenoma (PA) | Eye measures |
| Chapter II | visual acuity (VA) and visual fields (VF) | pituitary adenoma (PA) | Eye measures |
| Chapter II | visual acuity and field | pituitary adenoma resection | Eye measures |
| Chapter II | visual acuity、visual fields 、 visual impairment score (VIS) | tuberculum sellae meningiomas | Eye measures |
| Chapter II | visual fields (VFs), multifocal visual evoked potentials (mfVEP) | meningioma | Eye measures |
| Chapter II | visual function alterations | large-to-giant pituitary adenomas | Eye measures |
| Chapter II | visual outcome | clinoidal meningioma (CLM) | Eye measures |
| Chapter II | visual outcome | pituitary macroadenomas | Eye measures |
| Chapter II | visual outcome | tuberculum sellae and diaphragm sellae meningiomas. | Eye measures |
| Chapter II | vitreous cells | small-cell carcinoma of the lung (SCCL) | Eye measures |
| Chapter II | vogt-koyanagi-harada disease (VKHD) | melanoma | Disease |
| Chapter II | wet age-related macular disease | a clear cell renal cell carcinoma | Disease |
| Chapter II | xerophthalmia | gastrointestinal neoplasia | Disease |